DK0674621T3 - Enantiomerer af carbazolderivater som 5-HT1-lignende agonister - Google Patents

Enantiomerer af carbazolderivater som 5-HT1-lignende agonister

Info

Publication number
DK0674621T3
DK0674621T3 DK94903845T DK94903845T DK0674621T3 DK 0674621 T3 DK0674621 T3 DK 0674621T3 DK 94903845 T DK94903845 T DK 94903845T DK 94903845 T DK94903845 T DK 94903845T DK 0674621 T3 DK0674621 T3 DK 0674621T3
Authority
DK
Denmark
Prior art keywords
pct
agonists
enantiomers
carbazole derivatives
date jul
Prior art date
Application number
DK94903845T
Other languages
Danish (da)
English (en)
Inventor
Gary Thomas Borrett
John Kitteringham
Roderick Alan Porter
Mark Ralph Shipton
Mythily Vimal
Rodney Christopher Young
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Application granted granted Critical
Publication of DK0674621T3 publication Critical patent/DK0674621T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94903845T 1992-12-21 1993-12-16 Enantiomerer af carbazolderivater som 5-HT1-lignende agonister DK0674621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226530A GB9226530D0 (en) 1992-12-21 1992-12-21 Compounds
PCT/EP1993/003627 WO1994014772A1 (en) 1992-12-21 1993-12-16 Enantiomers of carbazole derivatives as 5-ht1-like agonists

Publications (1)

Publication Number Publication Date
DK0674621T3 true DK0674621T3 (da) 2003-06-10

Family

ID=10726909

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94903845T DK0674621T3 (da) 1992-12-21 1993-12-16 Enantiomerer af carbazolderivater som 5-HT1-lignende agonister

Country Status (18)

Country Link
US (2) US5618947A (es)
EP (1) EP0674621B1 (es)
JP (1) JP3364222B2 (es)
KR (1) KR100307001B1 (es)
CN (1) CN1039491C (es)
AT (1) ATE233239T1 (es)
AU (1) AU688748B2 (es)
CA (1) CA2152630C (es)
DE (1) DE69332718T2 (es)
DK (1) DK0674621T3 (es)
ES (1) ES2193151T3 (es)
GB (1) GB9226530D0 (es)
HK (1) HK1012368A1 (es)
MX (1) MX9400035A (es)
NZ (1) NZ259363A (es)
PT (1) PT674621E (es)
WO (1) WO1994014772A1 (es)
ZA (1) ZA939457B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
AU1407399A (en) * 1997-11-14 1999-06-07 Eli Lilly And Company Treatment for alzheimer's disease
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
FR2841899A1 (fr) * 2002-07-05 2004-01-09 Ppg Sipsy Procede de resolution asymetrique d'un racemique faisant intervenir l'acide diprogulique et utilisation dudit acide comme agent de resolution asymetrique
EP1856126A2 (en) * 2005-02-17 2007-11-21 Wyeth a Corporation of the State of Delaware Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
WO2010073253A1 (en) * 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2010122343A1 (en) * 2009-04-23 2010-10-28 Generics [Uk] Limited A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
WO2011095803A1 (en) * 2010-02-02 2011-08-11 Generics [Uk] Limited Hplc method for analyzing frovatriptan
WO2012147020A1 (en) * 2011-04-25 2012-11-01 Orchid Chemicals And Pharamceuticals Limited An improved process for the preparation of frovatriptan
EP2816030A1 (en) * 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
CN104402798B (zh) * 2014-10-21 2016-09-14 杭州瑞德化工有限公司 一种3-氨基-1，2，3，4-四氢咔唑的拆分方法
CN104529871A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种琥珀酸呋罗曲坦的制备方法
US11405689B2 (en) * 2020-12-09 2022-08-02 Rovi Guides, Inc. Systems and methods for providing recording of a blacked-out media content item

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
JPS6429699A (en) * 1987-07-24 1989-01-31 Mitsubishi Heavy Ind Ltd Recovery method for adiabatic compression heat
US4874399A (en) * 1988-01-25 1989-10-17 Minnesota Mining And Manufacturing Company Electret filter made of fibers containing polypropylene and poly(4-methyl-1-pentene)
JPH0247924A (ja) * 1988-08-08 1990-02-16 Nec Corp 分周回路
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments

Also Published As

Publication number Publication date
WO1994014772A1 (en) 1994-07-07
CA2152630A1 (en) 1994-07-07
KR950704253A (ko) 1995-11-17
HK1012368A1 (en) 1999-07-30
DE69332718T2 (de) 2003-12-04
AU5814594A (en) 1994-07-19
AU688748B2 (en) 1998-03-19
EP0674621A1 (en) 1995-10-04
JP3364222B2 (ja) 2003-01-08
US5650426A (en) 1997-07-22
KR100307001B1 (ko) 2001-12-28
GB9226530D0 (en) 1993-02-17
EP0674621B1 (en) 2003-02-26
ZA939457B (en) 1995-06-19
CA2152630C (en) 2005-07-26
PT674621E (pt) 2003-07-31
MX9400035A (es) 1994-07-29
ES2193151T3 (es) 2003-11-01
ATE233239T1 (de) 2003-03-15
CN1039491C (zh) 1998-08-12
JPH08504790A (ja) 1996-05-21
DE69332718D1 (de) 2003-04-03
CN1095712A (zh) 1994-11-30
NZ259363A (en) 1996-12-20
US5618947A (en) 1997-04-08

Similar Documents

Publication Publication Date Title
DK0674621T3 (da) Enantiomerer af carbazolderivater som 5-HT1-lignende agonister
GB9203347D0 (en) Hypolipidaemic compounds
MX9504349A (es) Derivados de aroilpiperidina.
CY1109915T1 (el) Φαρμακευτικες συνθεσεις οιστρογονων μεσων
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
DK0607193T3 (da) Antifugale triazolderivater
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
HUT59124A (en) Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
KR960703401A (ko) 약학적 활성을 갖는 피리다지논 유도체[pyridazinone derivatives with pharmaceutical activity]
FI913713A0 (fi) Nya bicykliska aminosubstituerade foereningar.
ES8500742A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
HU886767D0 (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients
ATE109475T1 (de) Benzothiazolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
FI955707A (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina